The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...
The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...
Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...
Tizanidine HCl 4mg (quadrisecting score). Initially 2mg; may repeat every 6–8hrs as needed, up to max 3 doses in 24hrs. May increase gradually by 2–4mg, with 1–4 days between dose increases; max ...
Patients with baseline viral suppression maintained viral suppression, while those without achieved viral suppression by 13 ...
HealthDay News — Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November issue of The Lancet ...
Strong recommendations include distinguishing bothersome from nonbothersome tinnitus, asking about risks for self-harm.
The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.
The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...
Accelerated approval is supported by 34-week interim data from the phase 3 I CAN trial showing a statistically significant 43% placebo-adjusted reduction in proteinuria.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results